ArticleJournal of cancer research and clinical oncology2017
Unmonitored use of herbal medicine by patients with breast cancer: reframing expectations.
Article in Journal of cancer research and clinical oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03954509 (Needs Assessment of Cancer Patients With Complementary and Alternative Medicines), which is not on this map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Needs Assessment of Cancer Patients With Complementary and Alternative Medicines
Who cites it
17 citing papers in PubMed, 27 citations in OpenAlex.
- Integrative oncology: evolution, framework, and future directions.Frontiers in oncology · 2026Article
- Cross-Cultural Patient Counseling and Communication in the Integrative Medicine Setting: Respecting the Patient's Health Belief Model of Care.Current psychiatry reports · 2024Review
- Dietary supplement beliefs and use patterns among Irish patients with early-stage breast cancer.Irish journal of medical science · 2024Article
- Integrative Medicine for Cancer-Related Pain: A Narrative Review.Healthcare (Basel, Switzerland) · 2024Review
- Knowledge and attitudes towards medicinal cannabis and complementary and integrative medicine (CIM): a survey of healthcare professionals working in a cancer hospital in Australia.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023Article
- Identifying cultural, demographic, personal health and cancer-related barriers to integrative oncology care: a retrospective case-cohort study.Journal of cancer research and clinical oncology · 2023Article
- Integrative Medicine for Ovarian Cancer.Current oncology reports · 2023Review
- Use of Herbal Medicine Is Associated With Late-Stage Presentation in Tanzanian Patients With Cancer: A Survey to Assess the Utilization of and Reasons for the Use of Herbal Medicine.JCO global oncology · 2022Article
- Trends in integrative medicine and health consults: differences between cancer survivors and patients without cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021Article
- Exploring Herbal Medicine Use during Palliative Cancer Care: The Integrative Physician as a Facilitator of Pharmacist-Patient-Oncologist Communication.Pharmaceuticals (Basel, Switzerland) · 2020Review
- Simultaneous Determination of Schisandrin and Promethazine with Its Metabolite in Rat Plasma by HPLC-MS/MS and Its Application to a Pharmacokinetic Study.International journal of analytical chemistry · 2019Article
- News from the European Association for Cancer Education: a Long-standing Partner of AACE.Journal of cancer education : the official journal of the American Association for Cancer Education · 2018Article
- Refugees in Conflict: Creating a Bridge Between Traditional and Conventional Health Belief Models.The oncologist · 2018Article
- Understanding CAM Use in Lebanon: Findings from a National Survey.Evidence-based complementary and alternative medicine : eCAM · 2018Article
- The Cytochrome P450-Mediated Metabolism Alternation of Four Effective Lignans FromFrontiers in pharmacology · 2018Article
- Integrative cancer care: crossing communication barriers.Oncotarget · 2017Article
- Expectations of Patients and Their Informal Caregivers from an Integrative Oncology Consultation.Integrative cancer therapiesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo identify the unmonitored use of herbal medicine by female patients with breast cancer, examining the impact of an integrative physician (IP) consultation on this practice.
methodsThe files of 269 female patients with breast cancer following an IP consultation were surveyed retrospectively for use of herbal medicine for cancer-related goals. Expectations from the IP consultation and adherence to the IP-guided treatments were examined as well.
resultsAmong the cohort, 111 (41.3%) reported using herbal medicine for cancer-related goals, unmonitored by their oncology healthcare professional. Factors predicting herbal medicine use were the adoption of dietary changes (odds ratio = 13.6, p < 0.001, CI 7.16-26.0) and the expectation that the IP consultation and treatments would address cancer-related goals (odds ratio = 3.29, p = 0.001, CI 1.64-6.6). Patients with metastatic disease were more likely to be using herbal medicine than non-users (34.5 vs. 22.8%; p = 0.088), as were those who had consulted with a complementary/alternative medicine practitioner (54.9 vs. 20.8%; p = 0.005). The IP advised 17 patients (15.3%) to stop taking specific herbal products due to safety-related concerns; and 10 patients to take dietary supplements for relief of specific symptoms. Herbal medicine users were less likely than non-users to adhere to the IP-recommended treatment program (34.7 vs. 48.3%; p = 0.037).
conclusionsUnmonitored use of herbal medicine by patients with breast cancer is more frequent among those adopting dietary changes for cancer-related goals. Integrative physicians provide evidence-based guidance on the safe and effective use of herbal products, and reframe patient expectations from cancer-related goals to reducing symptoms and improving quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.